DERM Profile
Journey Medical Corporation is a specialized biopharmaceutical company dedicated to developing and commercializing advanced treatments for dermatological conditions in the United States. Established in 2014 and headquartered in Scottsdale, Arizona, the company has built a diverse portfolio of products aimed at addressing various skin disorders. Journey Medical's flagship offerings include Qbrexza, a medicated cloth towelette designed to treat primary axillary hyperhidrosis, and Accutane, an oral isotretinoin used for severe recalcitrant acne.
The company's product lineup also features Targadox, an oral doxycycline formulation intended for adjunctive therapy in severe acne cases, and Ximino, an oral minocycline drug for treating moderate to severe acne. Additionally, Journey Medical markets Exelderm, a topical cream and solution, as well as doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution. These products collectively address a range of dermatological needs from acne and hyperhidrosis to fungal infections.
Journey Medical Corporation’s focus on dermatology underscores its commitment to advancing skin health through innovative pharmaceutical solutions. The company's strategic emphasis on targeting significant unmet medical needs within dermatology reflects its dedication to improving patient outcomes and providing effective treatments for complex skin conditions.
Formerly known as Coronado Dermatology, Inc., Journey Medical Corporation underwent a rebranding to better align with its expanded mission and product offerings. With a strong foundation in dermatological therapeutics and a growing portfolio, Journey Medical continues to lead advancements in the field, leveraging its expertise and market presence to address critical dermatological challenges.
|
